Vitamin K2 and Testosterone: What the Research Shows for Men Over 40

The connection between vitamin K2 and testosterone runs through an unexpected organ: your bones.

Osteoblasts, the cells that build bone, secrete a protein called osteocalcin. When vitamin K2 is present at adequate levels, it activates carboxylase enzymes that chemically modify osteocalcin, converting it from an inactive precursor into a circulating hormone. That activated osteocalcin travels through the bloodstream to the testes, where it binds to receptors on Leydig cells and drives testosterone synthesis upward.

This pathway was established by Gerard Karsenty's laboratory at Columbia University in a 2011 paper published in Cell (Oury et al.). Mice lacking the osteocalcin receptor on Leydig cells produced substantially less testosterone than controls. Infusing osteocalcin into these mice restored testosterone production. The evidence is mechanistically clear: osteocalcin is a testosterone-stimulating signal, and vitamin K2 is the activator that makes osteocalcin work.

For men over 40 eating a standard Western diet, this mechanism matters in a concrete way. Western diets deliver approximately 10 to 30 mcg of vitamin K2 per day. Japanese traditional diets with regular natto intake deliver 200 to 500 mcg. Men avoiding fermented foods likely have undercarboxylated osteocalcin circulating at high levels, meaning the testosterone-stimulating signal is present as protein but biologically inactive. This is a correctable situation.

In this article:

• What vitamin K2 is
• The osteocalcin-testosterone connection
• Animal studies
• Human studies
• Who is vitamin K2 deficient
• Food sources vs. supplements
• Who benefits most
• Dosage and form
• How it fits into a testosterone protocol
• FAQ

Key Takeaways

What Vitamin K2 Is

Vitamin K exists in two biological forms that function differently despite sharing a chemical scaffold.

Vitamin K1 (phylloquinone) is found in leafy greens and handled predominantly by the liver for clotting factor activation. The body converts a small fraction to K2, but not enough to saturate tissue demands outside the liver. Eating more spinach does not meaningfully raise osteocalcin carboxylation.

Vitamin K2 (menaquinone) is a family of compounds numbered MK-4 through MK-13, differing in side chain length. MK-4 is the form found in egg yolks, meat, and poultry; the body can also synthesize it in tissue from K1 conversion. MK-7 is produced by bacterial fermentation and found at high concentrations in natto and aged hard cheeses. The critical pharmacokinetic difference: MK-7's longer side chain extends its plasma half-life to approximately 72 hours, while MK-4 clears in 3 to 5 hours. A single daily dose of MK-7 maintains tissue levels across the day; MK-4 requires multiple daily doses to achieve comparable tissue distribution.

Both forms activate the same enzyme class: vitamin K-dependent gamma-glutamyl carboxylases. These enzymes carboxylate specific glutamate residues in target proteins, converting them from inactive to active forms. For testosterone, the target protein is osteocalcin. Adequate K1 for clotting factor production in the liver does not guarantee adequate K2 for osteocalcin carboxylation in bone. The liver's clotting demand takes priority under restricted intake.

The Osteocalcin-Testosterone Connection

Osteocalcin is secreted by osteoblasts and, when carboxylated by vitamin K2, acts as an endocrine hormone with effects extending far beyond bone.

The 2011 Cell paper by Oury and colleagues established the testosterone connection in mechanistic detail. Male mice lacking GPRC6A receptors on Leydig cells showed significantly reduced testosterone and impaired fertility. Osteocalcin infusion into these mice restored testosterone production. Mice that overexpressed osteocalcin showed elevated testosterone and enhanced male fertility markers. The pathway is bidirectional and receptor-mediated: osteocalcin signals, GPRC6A receives, and Leydig cells respond by increasing steroidogenic enzyme expression.

The mechanism inside Leydig cells operates through cAMP signaling. Osteocalcin binding to GPRC6A elevates intracellular cyclic AMP, which upregulates expression of StAR protein, CYP11A1, and CYP17A1. StAR transports cholesterol into mitochondria; CYP11A1 converts cholesterol to pregnenolone; CYP17A1 converts pregnenolone toward testosterone downstream. Osteocalcin does not create new steroidogenic machinery. It upregulates existing machinery and accelerates the conversion rate.

For men over 40, this pathway functions only as well as the upstream carboxylation allows. Undercarboxylated osteocalcin cannot bind GPRC6A with adequate affinity to trigger this cascade. The protein may circulate in quantity while delivering essentially no testosterone signal.

Animal Studies

The Karsenty laboratory's mouse data established the osteocalcin pathway. Additional animal work extended the findings to vitamin K2 status directly.

Male mice fed vitamin K-deficient diets show elevated ratios of undercarboxylated to carboxylated osteocalcin and correspondingly lower testosterone than K-adequate controls. When K2 is restored, osteocalcin carboxylation recovers and testosterone rises with it. The correlation is consistent across multiple rodent studies examining K-dependent protein status and gonadal function.

Aging rodent models are relevant for men over 40. Older male rats show greater undercarboxylation of osteocalcin than young animals on identical diets, consistent with age-related reductions in K2 absorption efficiency and the cumulative effect of dietary K2 inadequacy over years. In these aged animals, testosterone tracks osteocalcin carboxylation status more closely than in young animals, suggesting the osteocalcin-testosterone axis becomes an increasing proportion of residual testosterone production capacity as other hormonal inputs decline with age.

The animal data does not translate directly to men, but the receptor biology is shared. GPRC6A is expressed in human Leydig cells, and its activation profile in human tissue matches what the mouse studies predict. This provides a strong biological rationale for expecting the same relationship in human populations.

Human Studies

Human evidence on vitamin K2 and testosterone is smaller than the animal literature but directionally consistent with the mechanism.

Cross-sectional data from population studies show positive associations between higher K2 intake and better hormonal and metabolic profiles in men. The Rotterdam Study cohort, published in Thrombosis and Haemostasis (Gast et al., 2009), found that men in the highest tertile of dietary menaquinone intake had significantly lower rates of coronary heart disease and better metabolic markers than those in the lowest tertile. The study captured total K2 intake from diet without measuring testosterone as an endpoint, but the metabolic pattern is consistent with what elevated osteocalcin signaling would predict.

More targeted evidence comes from Japanese studies examining MK-4 at pharmacological doses. Men receiving 45 mg per day of MK-4 (the clinical dose used for osteoporosis treatment in Japan, equivalent to approximately 45,000 mcg) showed testosterone-relevant hormonal improvements in several small trials. At this dose level, direct pharmacological effects on Leydig cells likely operate alongside the osteocalcin pathway, making it difficult to isolate which mechanism drove observed changes. Results from pharmacological doses do not predict results from nutritional supplementation.

At nutritional MK-7 doses (100 to 200 mcg per day), dedicated human RCTs measuring testosterone as a primary outcome are limited. What does exist: carboxylation studies confirming that MK-7 at 180 mcg per day reduces undercarboxylated osteocalcin significantly within four weeks. The downstream hormonal consequences of that carboxylation improvement in testosterone-focused trials remain an active research question.

The honest position on the evidence: the mechanistic case for K2 supporting testosterone is strong. Human trial data directly connecting nutritional K2 to testosterone changes is limited. Men with dietary K2 insufficiency are most likely to see measurable effects.

Who Is Vitamin K2 Deficient

Vitamin K2 deficiency follows dietary patterns rather than geography. Unlike selenium, where soil composition drives regional differences, K2 inadequacy in Western populations reflects the displacement of traditional fermented foods by processed alternatives.

The fermented food gap. Japanese men eating traditional diets with regular natto intake consume 200 to 500 mcg of MK-7 per day. Men in the US and UK eating standard diets without fermented dairy or fermented soy products consume 10 to 30 mcg of total K2, primarily as short-lived MK-4 from animal products. The two populations are in different functional categories for osteocalcin carboxylation.

Dietary patterns that indicate likely K2 insufficiency:

• Men avoiding dairy (no aged cheese, no butter)
• Men following low-fat diets (K2 is fat-soluble; fat restriction reduces absorption)
• Men with minimal egg yolk consumption and no fermented food intake
• Men with fat malabsorption conditions: Crohn's disease, celiac disease, pancreatitis, post-bariatric surgery
• Men taking long-term antibiotics or with significant gut dysbiosis (intestinal bacteria contribute to MK-4 synthesis)

The carboxylation proxy. The practical indicator of K2 status is the ratio of undercarboxylated to total osteocalcin (ucOC:total OC), available through specialty labs. A ratio above 20% suggests inadequate carboxylation. Serum K2 reflects recent intake only and does not capture chronic insufficiency. For most men, a dietary audit is the fastest first step: count your weekly servings of aged hard cheese and egg yolks. If the combined total falls below five to seven per week, K2 insufficiency is probable.

Leafy vegetables do not solve this. Spinach, broccoli, and kale contain abundant K1 that satisfies hepatic clotting demands. They deliver negligible K2. Men who think they are vitamin K replete because they eat vegetables may have adequate K1 for coagulation and inadequate K2 for osteocalcin activation simultaneously.

Food Sources vs. Supplements

Natto is the only food that delivers pharmacologically relevant MK-7 in a standard serving. Two tablespoons provides over 150 mcg of MK-7 with high bioavailability. The barrier is palatability: the smell and texture of fermented soybeans prevent most Western men from eating natto daily. Gouda and aged hard cheeses are the next-best Western sources.

Men who eat 100g of gouda-style cheese daily reach approximately 75 mcg of K2, primarily as long-chain menaquinones. This approaches the lower end of effective supplemental doses through diet alone. Men who rely on eggs and butter without aged cheese fall significantly short of osteocalcin saturation thresholds.

For men who will not eat aged cheese daily, MK-7 supplementation at 100 to 200 mcg per day is the practical solution. MK-7 supplements maintain consistent serum levels between daily doses. Taking MK-7 with a fatty meal increases absorption 2 to 3 times compared to fasted intake.

Who Benefits Most

Men with low dietary K2 intake. This group is large. Any man eating a standard American or British diet without daily aged hard cheese and without natto is almost certainly K2-insufficient. This is the base case for supplementation.

Men over 40 with declining testosterone. The osteocalcin-testosterone axis provides a modifiable input to Leydig cell function. Restoring this signal through K2 adequacy does not replace declining LH pulsatility or increasing SHBG with age, but it removes a correctible suppressant of testosterone output. Understanding your testosterone levels by age alongside micronutrient status gives context for how much this correction is likely to matter in your situation.

Men already taking vitamin D3. Vitamin D increases osteocalcin gene expression in osteoblasts, producing more of the protein. Without K2, that additional osteocalcin remains undercarboxylated and inactive. D3 without K2 raises inactive osteocalcin. D3 combined with K2 raises active osteocalcin. Men taking vitamin D for testosterone support get more from it when K2 is also adequate.

Men with metabolic syndrome or insulin resistance. Osteocalcin has insulin-sensitizing properties alongside its testosterone-stimulating function. The same carboxylation status that affects testosterone also affects glucose metabolism. The relationship between insulin resistance and low testosterone means men addressing metabolic health gain a parallel benefit from correcting K2 status.

Men with elevated SHBG. Vitamin K2 may reduce SHBG through thyroid-adjacent effects as thyroid-dependent SHBG elevation resolves with better K2-supported T4-to-T3 conversion. Men dealing with SHBG suppressing free testosterone who also have low dietary K2 have a secondary reason to correct it.

Dosage and Form

MK-7 is the preferred supplemental form. Its 72-hour half-life allows once-daily dosing with stable tissue levels. MK-4 clears too quickly at standard supplemental doses to maintain consistent concentrations between doses without three to four daily administrations.

Target dose: 100 to 200 mcg of MK-7 per day. This range is consistent with carboxylation saturation studies. The 180 mcg dose tested by Knapen and colleagues (Calcified Tissue International, 2007) reduced undercarboxylated osteocalcin significantly within four weeks in human subjects. Higher doses at the nutritional level do not appear to produce proportionally greater carboxylation effects.

Take with a fatty meal. K2 is fat-soluble. Absorption with fat is 2 to 3 times higher than fasted intake. Taking it with olive oil, nuts, or any meal containing 10 to 20g of fat ensures adequate absorption. A combined D3/K2 capsule taken with breakfast that includes eggs or butter is a practical single-product approach.

Combination D3/K2 supplements are a practical option for men addressing both micronutrients. Most products pair D3 at 2000 to 5000 IU with MK-7 at 100 to 200 mcg. The synergy is well-supported and the combination covers both the osteocalcin carboxylation gap and the vitamin D insufficiency that affects most Western men.

No established toxicity threshold exists for MK-7 at nutritional doses, and the NIH Office of Dietary Supplements Vitamin K fact sheet confirms that no Tolerable Upper Intake Level has been established for vitamin K supplementation in healthy adults. Unlike selenium with its documented upper limit, vitamin K2 at supplemental nutritional doses has not produced toxicity in long-term research. The exception: men on warfarin, acenocoumarol, or other vitamin K antagonists must discuss K2 supplementation with their prescriber before starting. K2 competes with these drugs' mechanism and can alter clotting factor production and medication dosing requirements.

How It Fits Into a Testosterone Protocol

Vitamin K2 belongs in the same foundational micronutrient layer as vitamin D, zinc, magnesium, selenium, and boron. These are not stimulants. They restore the biological conditions under which testosterone production operates at its natural ceiling. Correcting them does not push testosterone above your genetic potential. It prevents nutrient insufficiency from suppressing it below that potential.

Step 1: Audit dietary K2. Count your weekly servings of aged gouda-style cheese and egg yolks. If the total falls below five per week, assume K2 insufficiency. Add a 100 to 200 mcg MK-7 supplement or increase aged hard cheese to at least 100g per day.

Step 2: Pair with vitamin D3. The D3/K2 synergy is practical and well-supported. Take both together with a fatty meal. If you already take vitamin D for testosterone without K2, adding MK-7 activates the osteocalcin that D3 has been producing without converting.

Step 3: Address K2 before more targeted compounds. Adaptogens, LH stimulants, and SHBG reducers operate on different pathways than foundational micronutrients. The free testosterone protocol covers the full priority order for combining micronutrient corrections with more targeted interventions. Foundational micronutrients come first.

Step 4: Allow 8 to 12 weeks. Osteocalcin carboxylation improves within four to six weeks at 180 mcg MK-7 per day. Downstream hormonal changes at the Leydig cell level operate on a slower timeline. Assess with a full testosterone panel at 90 days to quantify the effect.

Where it shows in bloodwork. Men using the free testosterone calculator to track treatment progress should note that K2 improvements may shift both total testosterone and SHBG as thyroid-mediated SHBG elevation resolves. Run total T, free T, and SHBG at baseline and at 90 days. The SHBG guide covers how SHBG changes alter free testosterone calculations without necessarily changing total T on the standard panel.

FAQ

Does vitamin K2 increase testosterone?

Vitamin K2 activates osteocalcin, which stimulates testosterone production in Leydig cells via GPRC6A receptors. This mechanism is established in animal models and supported by shared receptor biology in human testicular tissue. Dedicated human RCTs measuring testosterone at nutritional MK-7 doses are limited but consistent with the mechanism. Men with dietary K2 insufficiency are most likely to see measurable testosterone effects from correction. Men already consuming adequate K2 from aged cheeses and fermented foods daily are less likely to see additional gains.

What is the difference between vitamin K1 and K2 for testosterone?

Vitamin K1 from leafy greens carboxylates clotting factors in the liver but does not effectively carboxylate osteocalcin in bone. Vitamin K2 (specifically MK-7) circulates for days, reaches bone and other peripheral tissues, and provides the carboxylation that activates osteocalcin's testosterone-stimulating function. For testosterone support, K2 is the relevant form. Eating more spinach does not meaningfully improve osteocalcin carboxylation.

Which form of K2 is better for testosterone, MK-4 or MK-7?

Both activate osteocalcin through the same carboxylase enzymes, but MK-7 is the better supplemental form. MK-4 clears from blood within hours, requiring multiple daily doses for sustained tissue levels. MK-7's 72-hour half-life makes once-daily dosing effective. From food, gouda and aged hard cheeses provide MK-7; egg yolks and organ meats provide MK-4. The pharmacological 45 mg MK-4 dose used in some Japanese studies is not applicable to nutritional supplementation decisions.

How much vitamin K2 should men over 40 take?

100 to 200 mcg of MK-7 per day is the studied range for osteocalcin carboxylation saturation. Take it with a fat-containing meal for full absorption. Men who eat 100g or more of aged gouda-style cheese daily may already reach this intake from food. Men with minimal fermented food intake need supplementation to reach target carboxylation levels.

Can I get enough K2 from cheese and eggs?

Gouda and aged hard cheeses at 100g per day provide approximately 75 mcg of K2 as long-chain menaquinones. Two eggs provide 15 to 25 mcg of MK-4. Together, daily servings of both approach the lower end of effective K2 intake. Men who eat substantial aged cheese daily with regular eggs get meaningful K2 from food. Men who avoid dairy need supplementation.

Is vitamin K2 safe with other testosterone supplements?

Vitamin K2 at nutritional doses (100 to 200 mcg MK-7) has an excellent safety profile with no documented negative interactions with supplements commonly used for testosterone support including magnesium, zinc, D3, ashwagandha, and tongkat ali. Men on anticoagulant medications (warfarin, acenocoumarol) must discuss K2 with their prescriber before starting, as it can alter coagulation factor production and change medication requirements.

Does vitamin K2 work better when taken with vitamin D3?

Yes. D3 upregulates osteocalcin gene expression in osteoblasts, increasing the amount of osteocalcin the body produces. K2 determines what fraction of that osteocalcin gets carboxylated and becomes biologically active. D3 without K2 raises inactive osteocalcin quantity. D3 with K2 raises active osteocalcin. Taking them together addresses both sides of the equation in a single daily supplement, and most combined D3/K2 products pair clinically relevant doses of each.

Consult your healthcare provider before starting any supplement program. Men taking anticoagulant medications should discuss vitamin K2 supplementation with their prescriber, as it can affect coagulation factor production and alter medication dosing requirements.